Immune-based therapies in pancreatic and colorectal cancers and biomarkers of responsiveness

Giuseppe Di Caro, Giovanni Francesco Castino, Francesca Bergomas, Nina Cortese, Maurizio Chiriva-Internati, Fabio Grizzi, Federica Marchesi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Immune-based strategies are the most promising treatments to improve cancer disease control. Early clinical trials are ongoing to test the safety and feasibility of immune-based therapies for gastrointestinal cancers. However, to date, immunotherapy has been only an experimental option for these diseases and a better understanding of their molecular, cellular, structural and clinical dissimilarities is crucial in the generation of tailored immunotherapeutic treatments. In this review, we will summarize the key mechanisms that regulate the action of immune system in cancer and the different immune-based approaches aimed at improving disease control in patients with advanced disease. We will then move on to discussing the current immunotherapeutic approaches in two types of gastrointestinal (colo-rectal and pancreatic) cancers, whose immune microenvironment has been lately object of intense analyses and has emerged as an important determinant of clinical outcome.

Original languageEnglish
Pages (from-to)1219-1228
Number of pages10
JournalExpert Review of Anticancer Therapy
Volume14
Issue number10
DOIs
Publication statusPublished - Oct 1 2014

Fingerprint

Tumor Biomarkers
Pancreatic Neoplasms
Colorectal Neoplasms
Gastrointestinal Neoplasms
Therapeutics
Rectal Neoplasms
Immunotherapy
Immune System
Neoplasms
Clinical Trials
Safety

Keywords

  • biomarkers
  • colo-rectal cancer
  • immunotherapy
  • pancreatic adenocarcinoma
  • tumor microenvironment

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology
  • Medicine(all)

Cite this

Immune-based therapies in pancreatic and colorectal cancers and biomarkers of responsiveness. / Di Caro, Giuseppe; Castino, Giovanni Francesco; Bergomas, Francesca; Cortese, Nina; Chiriva-Internati, Maurizio; Grizzi, Fabio; Marchesi, Federica.

In: Expert Review of Anticancer Therapy, Vol. 14, No. 10, 01.10.2014, p. 1219-1228.

Research output: Contribution to journalArticle

@article{68c749837f444523a0a32fa95d7c4340,
title = "Immune-based therapies in pancreatic and colorectal cancers and biomarkers of responsiveness",
abstract = "Immune-based strategies are the most promising treatments to improve cancer disease control. Early clinical trials are ongoing to test the safety and feasibility of immune-based therapies for gastrointestinal cancers. However, to date, immunotherapy has been only an experimental option for these diseases and a better understanding of their molecular, cellular, structural and clinical dissimilarities is crucial in the generation of tailored immunotherapeutic treatments. In this review, we will summarize the key mechanisms that regulate the action of immune system in cancer and the different immune-based approaches aimed at improving disease control in patients with advanced disease. We will then move on to discussing the current immunotherapeutic approaches in two types of gastrointestinal (colo-rectal and pancreatic) cancers, whose immune microenvironment has been lately object of intense analyses and has emerged as an important determinant of clinical outcome.",
keywords = "biomarkers, colo-rectal cancer, immunotherapy, pancreatic adenocarcinoma, tumor microenvironment",
author = "{Di Caro}, Giuseppe and Castino, {Giovanni Francesco} and Francesca Bergomas and Nina Cortese and Maurizio Chiriva-Internati and Fabio Grizzi and Federica Marchesi",
year = "2014",
month = "10",
day = "1",
doi = "10.1586/14737140.2014.947277",
language = "English",
volume = "14",
pages = "1219--1228",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "10",

}

TY - JOUR

T1 - Immune-based therapies in pancreatic and colorectal cancers and biomarkers of responsiveness

AU - Di Caro, Giuseppe

AU - Castino, Giovanni Francesco

AU - Bergomas, Francesca

AU - Cortese, Nina

AU - Chiriva-Internati, Maurizio

AU - Grizzi, Fabio

AU - Marchesi, Federica

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Immune-based strategies are the most promising treatments to improve cancer disease control. Early clinical trials are ongoing to test the safety and feasibility of immune-based therapies for gastrointestinal cancers. However, to date, immunotherapy has been only an experimental option for these diseases and a better understanding of their molecular, cellular, structural and clinical dissimilarities is crucial in the generation of tailored immunotherapeutic treatments. In this review, we will summarize the key mechanisms that regulate the action of immune system in cancer and the different immune-based approaches aimed at improving disease control in patients with advanced disease. We will then move on to discussing the current immunotherapeutic approaches in two types of gastrointestinal (colo-rectal and pancreatic) cancers, whose immune microenvironment has been lately object of intense analyses and has emerged as an important determinant of clinical outcome.

AB - Immune-based strategies are the most promising treatments to improve cancer disease control. Early clinical trials are ongoing to test the safety and feasibility of immune-based therapies for gastrointestinal cancers. However, to date, immunotherapy has been only an experimental option for these diseases and a better understanding of their molecular, cellular, structural and clinical dissimilarities is crucial in the generation of tailored immunotherapeutic treatments. In this review, we will summarize the key mechanisms that regulate the action of immune system in cancer and the different immune-based approaches aimed at improving disease control in patients with advanced disease. We will then move on to discussing the current immunotherapeutic approaches in two types of gastrointestinal (colo-rectal and pancreatic) cancers, whose immune microenvironment has been lately object of intense analyses and has emerged as an important determinant of clinical outcome.

KW - biomarkers

KW - colo-rectal cancer

KW - immunotherapy

KW - pancreatic adenocarcinoma

KW - tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=84907516144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907516144&partnerID=8YFLogxK

U2 - 10.1586/14737140.2014.947277

DO - 10.1586/14737140.2014.947277

M3 - Article

C2 - 25222571

AN - SCOPUS:84907516144

VL - 14

SP - 1219

EP - 1228

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 10

ER -